Healthcare and bioinformatics are associated with huge and high dimensionality data and inherent uncertainty. Quantum-inspired architectures are based on quantum mechanics, superposition, entanglement and interference, to redesign medical data processing operations in a more efficient way. Quantum-inspired neural networks have an initial positive response in genomics and medical imaging. Tensor network techniques compress the overall genomic sequences efficiently and quantum-inspired PCA show a small-scale improvement in feature retrieval of medical images. One of the most popular models is hybrid quantum-classical systems which are quantum-inspired processing with the reliability of the established machine learning. Nevertheless, there is a lot of poor implementations due to limitations. The existing quantum computers use noisy qubits and 0.1-1% error per qubit. Thousand to millions of logical qubits are needed to simulate drug-sized molecules with molecular simulation which will not be accessible until probably the 2030s. The basic obstacles are state preparation overhead, cost of measurement, decoherence and barren plateau problems. The most successful near-term approaches are quantum-inspired classical algorithms, tensor networks and optimization methods, in a conventional computer. These provide continuous advances in the discovery of drugs, optimization of personalized medicine and optimization of healthcare logistics without the need to have quantum hardware. Although quantum-enhanced molecular property prediction and clinical decision support are promising, clinical validation and benefits are limited and still going on. Even in the case of healthcare, it is most likely to take 10-20+ years before practical quantum advantage is realized due to quantum hardware breakthroughs and regulatory approval.
Healthcare and bioinformatics are associated with huge and high dimensionality data and inherent uncertainty. Quantum-inspired architectures are based on quantum mechanics, superposition, entanglement and interference, to redesign medical data processing operations in a more efficient way. Quantum-inspired neural networks have an initial positive response in genomics and medical imaging. Tensor network techniques compress the overall genomic sequences efficiently and quantum-inspired PCA show a small-scale improvement in feature retrieval of medical images. One of the most popular models is hybrid quantum-classical systems which are quantum-inspired processing with the reliability of the established machine learning. Nevertheless, there is a lot of poor implementations due to limitations. The existing quantum computers use noisy qubits and 0.1-1% error per qubit. Thousand to millions of logical qubits are needed to simulate drug-sized molecules with molecular simulation which will not be accessible until probably the 2030s. The basic obstacles are state preparation overhead, cost of measurement, decoherence and barren plateau problems. The most successful near-term approaches are quantum-inspired classical algorithms, tensor networks and optimization methods, in a conventional computer. These provide continuous advances in the discovery of drugs, optimization of personalized medicine and optimization of healthcare logistics without the need to have quantum hardware. Although quantum-enhanced molecular property prediction and clinical decision support are promising, clinical validation and benefits are limited and still going on. Even in the case of healthcare, it is most likely to take 10-20+ years before practical quantum advantage is realized due to quantum hardware breakthroughs and regulatory approval.
The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI\\\'s predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning's role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug- receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual\\\'s genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions.
The convergence of quantum computing and artificial intelligence (AI) presents a paradigm shift in healthcare, revolutionizing complex biological simulations, genomic data processing, and drug discovery innovations. Traditional computational methods, despite their advancements, often struggle with the sheer scale and complexity of biological data, limiting the speed and accuracy of medical breakthroughs. Quantum computing, with its ability to process vast datasets exponentially faster than classical computers, coupled with AI's predictive capabilities, offers a transformative solution for accelerating biomedical research and clinical applications. This paper explores quantum machine learning’s role in optimizing AI-driven molecular dynamics simulations for drug discovery. By leveraging quantum-enhanced algorithms, researchers can rapidly model molecular interactions, analyze drug-receptor binding affinities, and predict pharmacokinetics with unprecedented precision. Additionally, we examine quantum-assisted deep learning models for deciphering intricate biological mechanisms such as protein folding, epigenetic modifications, and metabolic pathway interactions, enabling more accurate predictions of disease progression and therapeutic targets. Furthermore, the integration of AI-quantum hybrid models in clinical diagnostics and imaging analytics is redefining personalized medicine. Quantum-enhanced deep learning facilitates high-resolution medical imaging, real-time anomaly detection, and optimized radiomic feature extraction, leading to early and more accurate disease diagnosis. In genomics, quantum computing significantly accelerates whole-genome sequencing and mutation analysis, paving the way for tailored treatment strategies based on an individual's genetic profile. Despite its promise, challenges such as quantum hardware limitations, data coherence issues, and ethical considerations must be addressed to ensure the practical implementation of quantum-AI healthcare solutions. This paper provides a comprehensive analysis of the potential, challenges, and future directions of quantum-AI synergy in transforming modern healthcare.
Quantum computing is a developing computational paradigm that uses the principles of quantum mechanics, like superposition and entanglement, to execute composite calculations beyond the abilities of conventional computers. Currently, implementation of this technology in medicine has the potential to revolutionize various domains like drug discovery, protein folding, genomics, medical imaging, and personalized healthcare. By allowing high-dimensional data processing and accurate molecular simulations, quantum computing may enhance biomedical research and thereby improving clinical decision-making. Moreover integrating quantum computing with artificial intelligence, mainly through quantum machine learning, further accelerates its capability to assess vast complex biological datasets and generate precise predictive models. Applications like disease prediction, drug response optimization, and advanced diagnostic imaging further validates its growing importance in modern healthcare. However, the implementation of quantum computing in medicine is presently limited by technical challenges, that includes decoherence, error correction, and scalability, as well as practical problems like high budgets and lack of skilled professionals. Moreover, ethical concerns play a major hurdle related to data privacy and healthcare inequality also require cautious consideration. In spite of these challenges, ongoing developments in hybrid quantum-classical systems and quantum algorithms reveal that a promising future, particularly placing quantum computing as an effective transformative force in next-generation medicine.
The quantum-inspired neural architecture has a transformative capability for high-efficiency signal processing in the field of bioinformatics. Incorporating the principles of quantum computing in combination with classic neural networks, hybrid models use quantum superposition, entanglement, and parallelism to tackle difficult problems in biological data. As an example, the Quantum Spiking Neural Network (QSNN) combined with Quantum Long Short-Term Memory (QLSTM) modules can perform dynamic pattern recognition on genomic sequences and protein interaction predictions, which outperforms data efficiency in classical deep learning models. Quantum kernel methods also provide additional improvements in semantic classification tasks where quantum similarity is calculated between the biological data points, as can be seen in the analysis of gene expression with Quantum Kernel Support Vector Machines (QK-SVM). Areas of application include the transcriptomics classification of cancer using quantum k-means clustering, the optimization of gene regulatory networks, and fast drug discovery by means of quantum-enhanced literature mining. Such architectures both lower computational complexity and accelerate convergence rates - quantum-inspired backpropagation mechanisms, as an example, optimize weight updates 30% faster than classical counterparts in molecular dynamics simulations. The convergence of quantum-inspired algorithms and bioinformatics promises to not only solve the scalability problem in multi-omics data but also explore new methods of real-time adaptive learning in noisy biological settings
Quantum computing has emerged as a disruptive paradigm which can transform the information heavy areas of knowledge such as precision medicine. The expanding needs of precision medicine based on customized therapy in the light of genomics, molecular profiling, and clinical data suggest that the computation tasks can demand computational capabilities unattainable by the traditional high-performance computing. Quantum algorithms, which are founded upon the laws of superposition, entanglement and quantum parallelism, offer a scale factor of exponential on a problem in genomics, drug discovery, medical imaging and biomarker discovery. This is a review article that is a narrative synthesis of emerging trends at the interface of quantum computing and precision medicine. In particular, it discusses women topics such as patient stratification and imaging analysis with quantum machine learning (QML), protein-ligand interactions and drug discovery with quantum chemistry simulations, and quantum-classical architectures to combine complex biomedical data with clinical decision-making. Initial implementations show evidence of proof-of-concept utility in accelerating the sequencing of genomes, improving the accuracy of diagnostic imaging, and improving treatment design. With those developments, there are still major issues, such as the problem of qubit coherence, scalability of algorithms, barriers to the integration of data, and ethical concerns about transparency and fair access. To overcome these obstacles, it is necessary to physically co-evolve domain-specific quantum algorithms, powerful error-correction protocols, and cloud-friendly frameworks that can connect biomedical research to current quantum computing devices. This review offers a roadmap on how quantum computing can be leveraged to drive precision medicine to scalable, interpretable, and patient-centered healthcare solutions by outlining both early uses and future opportunities.
Abstract Quantum computing and artificial intelligence (AI) are converging to reshape the future of healthcare. Modern medicine generates vast and complex datasets from imaging, genomics, wearable sensors, and real-time clinical records. While AI has already demonstrated significant potential in diagnostics, drug discovery, and personalised medicine, its progress is often constrained by high computational demand, limited interpretability, and energy inefficiency. Quantum computing offers a fundamentally different paradigm, using qubits, superposition, and entanglement to process high-dimensional data and explore solution spaces in parallel. This synergy-quantum-enhanced AI or quantum machine learning (QML)promises transformative capabilities across the healthcare continuum. This narrative review explores the foundations of quantum computing, the evolution of AI in medicine, and the points where these technologies intersect. Applications span a range of biomedical domains. In radiology and pathology, quantum-assisted classifiers can enhance both the speed and interpretability of image analysis. In drug discovery and genomics, variational quantum eigensolvers and hybrid quantum–classical models may accelerate molecular simulations and genome-wide association studies. In personalized medicine, quantum kernel methods enable more precise phenotype clustering and improve the accuracy of treatment response predictions. Operationally, quantum-AI integration also supports hospital logistics, ICU resource allocation, and supply-chain resilience. Despite these opportunities, significant challenges remain, including hardware limitations, data encoding bottlenecks, interpretability deficits, and regulatory ambiguity. Ethical concerns around privacy, equity, and compliance with frameworks such as HIPAA and GDPR must also be addressed. By mapping opportunities and risks, this review underscores that quantum-AI is no longer speculative but an emerging reality. Harnessing its potential requires multidisciplinary collaboration to translate qubits and algorithms into tangible improvements in patient outcomes, clinical trust, and system efficiency.